Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.

Abstract

The role of inhibin, activin, and follistatin in the pathophysiology of polycystic ovary syndrome (PCOS) was investigated by examining the expression of human inhibin/activin subunit, follistatin, and type II activin receptor (ActRII and -IIB) messenger ribonucleic acid (mRNA) signals (via in situ hybridization) and encoded proteins (via immunocytochemistry) in ovarian follicles (n = 42) from 6 women diagnosed with PCOS. The localization patterns in cellular compartments were compared to those in small antral follicles of comparable size (3-7 mm; n = 40) from 17 normal human ovaries. In small antral follicles of both normal and PCOS ovaries, mRNA signals for all three subunits of inhibin and activin (alpha, beta a, and beta b) were expressed in granulosa cells, whereas in the thecal cell layer, only alpha-subunit mRNA was expressed. The relative intensity of the alpha-subunit mRNA signal was distinctly different in granulosa and thecal cells between PCOS and normal follicles; in small antral follicles of normal ovaries, the alpha-subunit mRNA signal was stronger in the granulosa cell layer than in the thecal cells, and the reverse was found in the polycystic follicles. A light follistatin mRNA signal was found in the granulosa cells of normal small antral follicles, but no follistatin mRNA was detected in any cell type of PCOS follicles. ActRII and -IIB mRNAs were not detected in any cell layer in either normal or PCOS follicles. There were no notable differences in the protein localization pattern of the inhibin/activin system between the PCOS and normal ovaries. In both types of follicles, follistatin and alpha-, beta a-, and beta b-subunit cytoplasmic staining were observed in granulosa cells, as were their corresponding messages, with the exception of the undetectable follistatin mRNA signal in the PCOS follicles. In both normal and PCOS follicles, follistatin and beta a-subunit cytoplasmic staining were occasionally found in thecal interna cells, with no corresponding localization of mRNA, and alpha-subunit protein was not detected in thecal cells despite the presence of the alpha-subunit mRNA. ActRII and -IIB protein localizations were not examined due to the lack of available antisera. These results suggest that granulosa cells of small antral follicles are less active in polycystic than in normal ovaries with respect to inhibin alpha-subunit and follistatin mRNA expression. A consequence of these differences could be an increase in the availability of activin, relative to inhibin, in the arrested follicles in PCOS.

Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio

“…Furthermore, premature sensitivity of granulosa cells from small antral follicles to LH has been reported in PCOS [31], thus LH might also stimulate inhibin B production directly in granulosa cells. In contrast to these findings and theories, several studies demonstrated reduced expression of the α-subunit in PCOS granulosa cells, which, possibly regulated by elevated LH levels, might be responsible for decreased inhibin A and B concentrations in follicular fluid [32,33]. Furthermore, an acute stimulatory effect of LH could not be mimicked by administrating a single dose of hCG to PCOS patients [16].…”

Epidemiological, endocrine and metabolic features in Turner syndrome

“…However, a few girls did have detectable levels of inhibin A and/or B (40). During the normal menstrual cycle, inhibin B concentrations increase in the early follicular phase in response to the rising FSH concentration exerting negative feedback on the pituitary (41,42), and it is primarily produced by the granulosa cells of the small developing follicles (43). The inhibin A concentration increases prior to ovulation, increases further after ovulation, and reaches peak values in the mid-luteal phase, primarily being produced by the granulosa cells of the dominant follicle and the corpus luteum (41,44 (47).…”

Serum α-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level1

“…Such a conclusion was not unexpected in view of in vitro studies showing that inhibin enhanced both insulin-and LH-stimulated A production in cultured human TC (22,23). It has been previously proposed that abnormalities of the activin/inhibin paracrine or autocrine system may be involved in the hyperandrogenism of PCOS (45,48). Surprisingly, insulin appeared to not have a role in our theoretical multiple regression analysis model.…”

“…Jaatinen et al (44) and Roberts et al (45) effectively demonstrated in vitro, using in situ hybridization, that both GC and TC of normal and polycystic ovaries express inhibin subunit messenger ribonucleic acid. Moreover, ␣-subunit messenger ribonucleic acid levels were higher in TC compared to GC of polycystic ovaries, in contrast to the normal ovary (45,46). Accordingly, the serum levels of inhibin B in PCOS patients were significantly and positively correlated to the LH level in a recent study (47).…”